| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 24.53B | 36.17B | 17.87B | 6.73B | 9.08B |
| Gross Profit | 10.63B | 28.34B | 6.26B | -3.24B | -2.28B |
| EBITDA | 9.71B | 7.12B | 5.19B | -2.07B | 556.11M |
| Net Income | 1.06B | -784.60M | -1.74B | -5.11B | -3.81B |
Balance Sheet | |||||
| Total Assets | 82.70B | 84.75B | 89.41B | 97.09B | 94.19B |
| Cash, Cash Equivalents and Short-Term Investments | 8.23B | 9.03B | 10.77B | 14.34B | 13.46B |
| Total Debt | 59.45B | 63.11B | 65.87B | 74.57B | 61.59B |
| Total Liabilities | 72.99B | 76.54B | 79.04B | 83.71B | 71.73B |
| Stockholders Equity | 1.91B | 45.93M | 665.00M | 1.79B | 6.86B |
Cash Flow | |||||
| Free Cash Flow | 7.58B | 6.37B | 6.69B | -9.51B | -7.15B |
| Operating Cash Flow | 10.25B | 8.73B | 8.51B | -5.19B | -2.08B |
| Investing Cash Flow | -2.59B | -2.22B | -1.52B | -4.11B | -4.20B |
| Financing Cash Flow | -8.60B | -8.10B | -10.56B | 7.22B | 3.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$144.80B | 7.71 | 13.12% | 3.06% | 9.63% | 21.77% | |
62 Neutral | HK$8.74B | 3.36 | 73.50% | ― | 12.09% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$41.61B | 4.63 | 194.66% | 5.73% | 10.97% | 10.35% | |
56 Neutral | HK$30.00B | 5.55 | -11.87% | 5.92% | -1.98% | -49.13% | |
52 Neutral | HK$129.17B | 10.53 | 71.16% | 2.39% | 4.17% | -14.33% | |
43 Neutral | HK$13.71B | -39.90 | -3.22% | ― | -3.01% | -15200.00% |